Madison, WI, May 25, 2012 --(PR.com
)-- Cresa Madison recently represented Nexcyon Pharmaceuticals in a relocation to accommodate a company-wide expansion. Nexcyon moved to approximately 3,000 square feet at 644 East Washington Avenue from the University Research Park. The relocation will provide Nexcyon with the required space to increase their staff and will further solidify their growing business, formerly headquartered in Indiana, in the Badger State.
“The service we received from Cresa was outstanding,” stated Irene Clark, principal of Nexcyon, “Cresa is a very rare entity that considerably over-delivers compared to expectations.”
A veterinary pharmaceutical research and development company, Nexcyon has offices in Pendleton, Indiana and London, and strategic partners across North America, Western Europe, Australia and New Zealand.
Cresa, a Madison commercial tenant advisory firm, provided counsel during the lease negotiation, including the initial market survey, site selection, request-for-proposal process, financial analysis and strategic counsel.
Cresa is Wisconsin’s largest commercial real estate advisory firm that exclusively represents tenants and specializes in the delivery of fully integrated real estate services, including: transaction management, relocation planning and management, strategic planning, site selection and incentives, subleases and dispositions, lease administration, facilities consulting and facility acquisition. For more information, visit www.cresa.com.
About Nexcyon Pharmaceuticals, Inc.
Nexyon Pharmaceuticals is an innovative veterinary pharmaceutical research and development company with a robust, therapeutically diverse pipeline of products being developed to meet the needs of veterinarians and pet owners. For more information please send a message to firstname.lastname@example.org or visit their website at www.procyonpharma.com.